Connection

Mark Hamner to Cross-Over Studies

Back to Details
This is a "connection" page, showing publications Mark Hamner has written about Cross-Over Studies.
Mark Hamner
Connection Strength
0.218
Cross-Over Studies
  1. Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
    View in: PubMed
    Score: 0.185
  2. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017 Aug; 234(15):2245-2257.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.